Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Anticuerpos Primarios

Anti-Mouse PD-L1 Recombinant Nanobody (C3) (MV974033)

Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Anti-Mouse PD-L1 Recombinant Nanobody (C3)
Precio(USD):
Especificación:
  • 50ug
  • 100ug
  • 1mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoMV974033
Descripción
Anti-Mouse CD274/PD-L1/B7-H1 Nanobody (C3) [C3] (MV974033) is a alpaca monoclonal antibody detecting B7-H1 in ELISA, FuncS. Suitable for Mouse.
Reactividad de especiesMouse
AplicacionesELISA, FuncS, WB
Especie huéspedAlpaca
ClonalidadMonoclonal
IsotipoVHH-8His-Cys-tag
ID de clonC3
Aplicaciones probadas WB
Objetivo B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Purified by Nickel column.
Número de acceso Q9EP73
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto
Aplicación Dilución
ELISA 1:2000-1:20000
WB 1:500-1:2000
Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo

Programmed cell death 1 ligand 1 (CD274/PD-L1) is a ~32 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). CD274 is the therapeutic target of atezolizumab (Tecentriq) and durvalumab (Imfinzi).

1. Tamura, H. et al. (2001) Blood 97, 1809-16. PMID: 11238124
2. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443
3. Wang, S. et al. (2003) The Journal of experimental medicine 197, 1083-91. PMID: 12719480
Nota For research use only.
Imágenes
  • Anti-Mouse PD-L1 Recombinant Nanobody (C3)

    SDS-PAGE

    SDS-PAGE for Anti-Mouse CD274/PD-L1/B7-H1 Nanobody (C3)

  • Anti-Mouse PD-L1 Recombinant Nanobody (C3)

    Bioactivity

    Detects recombinant mouse PDL1 (Catalog No: MV974011) in indirect ELISA.

  • Anti-Mouse PD-L1 Recombinant Nanobody (C3)

    Western blot

    Western blot analysis was performed using anti-PDL1 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant mouse PDL1 (Catalog No: MV974011)

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores